To our knowledge, this was the first meta-analysis to explore the association of ADRB1 and ADRB2 polymorphisms with cardiovascular events and all-cause mortality in CAD patients, and the results suggested that ADRB2 rs1042714 presented a positive association with cardiovascular events but not with all-cause mortality in CAD patients. The gene discussed is ADRB2; the disease is coronary artery disorder.